- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00179595
Does the Relaxation Response Inhibit Acute Stress?
The purposes of this study are:
- To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
- To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
Since stress is a factor in the development of many health conditions, a further understanding of the mechanisms of the RR should be developed. The project is designed to determine how the RR can improve the quality of life that has been adversely affected by stress.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The purposes of this study are:
- To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
- To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
Since stress is a factor in the development of many health conditions, a further understanding of the mechanisms of the RR should be developed. The project is designed to determine how the RR can improve the quality of life that has been adversely affected by stress.
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02215
- Beth-Israel Deaconess Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- healthy individual
- age:18-49 years
- able to read and understand English
- able to attend al study visits
- access to a telephone (to schedule visits)
Exclusion Criteria:
- current smoking
- asthma
- current use of any prescription or psychoactive medications or supplements
either:
- no prior experience with RR eliciting techniques
- at least 3 years of regular RR elicitation (at least 20 min/day)
- BMI >30
- exhaled nitric oxide levels >60 ppb
- abnormal lab values (Hct <32,creatinine >1.3, glucose >200
- pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
To examine molecular and biochemical changes, associated with the relaxation response (RR) that can counteract the effects of stress in healthy adults.
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
To compare genomic, molecular and biochemical parameters between healthy adults with a long term meditative practice and those with no experience in meditation.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Herbert Benson, MD, Beth Israel Deaconess Medical Center
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2001P001747
- H75-CCH-123424
- H75-CCH-119124
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.